These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22705363)

  • 21. Healthcare costs associated with treatment of bipolar disorder using a mood stabilizer plus adjunctive aripiprazole, quetiapine, risperidone, olanzapine or ziprasidone.
    Jing Y; Kim E; You M; Pikalov A; Tran QV
    J Med Econ; 2009 Jun; 12(2):104-13. PubMed ID: 19527195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic modulation of the P50 auditory-evoked potential in a computer model of the CA3 region of the hippocampus: its relationship to sensory gating in schizophrenia.
    Moxon KA; Gerhardt GA; Adler LE
    Biol Cybern; 2003 Apr; 88(4):265-75. PubMed ID: 12690485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
    Mukundan A; Faulkner G; Cohn T; Remington G
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy.
    Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S
    J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of novel antipsychotics in the older patient with neurodegenerative disorders in the long-term care setting.
    Kasckow JW; Mulchahey JJ; Mohamed S
    J Am Med Dir Assoc; 2004; 5(4):242-8. PubMed ID: 15228634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P50 gating in deficit and nondeficit schizophrenia.
    Santos JL; Sánchez-Morla EM; Aparicio A; García-Jiménez MA; Villanueva C; Martínez-Vizcaíno V; Arango C
    Schizophr Res; 2010 Jun; 119(1-3):183-90. PubMed ID: 20153607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching antipsychotic medications: not enough, too often, or just right?
    Weiden PJ
    Am J Psychiatry; 2011 Sep; 168(9):882-4. PubMed ID: 21890800
    [No Abstract]   [Full Text] [Related]  

  • 29. Sensory gating in adult with attention-deficit/hyperactivity disorder: Event-evoked potential and perceptual experience reports comparisons with schizophrenia.
    Micoulaud-Franchi JA; Vaillant F; Lopez R; Peri P; Baillif A; Brandejsky L; Steffen ML; Boyer L; Richieri R; Cermolacce M; Bioulac S; Aramaki M; Philip P; Lancon C; Vion-Dury J
    Biol Psychol; 2015 Apr; 107():16-23. PubMed ID: 25766264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of discontinuation of atypical antipsychotic agents in the treatment of schizophrenia.
    Mullins CD; Obeidat NA; Cuffel BJ; Naradzay J; Loebel AD
    Schizophr Res; 2008 Jan; 98(1-3):8-15. PubMed ID: 17596914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aripiprazole versus other atypical antipsychotics for schizophrenia.
    Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
    Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.
    Yamashita H; Mori K; Nagao M; Okamoto Y; Morinobu S; Yamawaki S
    J Clin Psychiatry; 2004 Nov; 65(11):1525-30. PubMed ID: 15554767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturalistic studies of second generation antipsychotics in the treatment of schizophrenia.
    Sebastian CS; Glazer W; Buckley PF
    Curr Med Chem; 2004 Feb; 11(3):329-42. PubMed ID: 14965235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
    Correll CU; Manu P; Olshanskiy V; Napolitano B; Kane JM; Malhotra AK
    JAMA; 2009 Oct; 302(16):1765-73. PubMed ID: 19861668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in weight and weight-related quality of life in a multicentre, randomized trial of aripiprazole versus standard of care.
    Kolotkin RL; Corey-Lisle PK; Crosby RD; Kan HJ; McQuade RD
    Eur Psychiatry; 2008 Dec; 23(8):561-6. PubMed ID: 18374544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics.
    Kumari V; Antonova E; Geyer MA; Ffytche D; Williams SC; Sharma T
    Int J Neuropsychopharmacol; 2007 Aug; 10(4):463-77. PubMed ID: 16923324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Managing the acutely agitated and psychotic patient.
    Nordstrom K; Allen MH
    CNS Spectr; 2007 Oct; 12(10 Suppl 17):5-11. PubMed ID: 17934384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antipsychotic dosing: still a work in progress.
    Remington G
    Am J Psychiatry; 2010 Jun; 167(6):623-5. PubMed ID: 20516160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.